Latest News

Dr Reddy’s launches Palonosetron Hydrochloride Injection in US

Dr Reddy’s Laboratories Limited has launched Palonosetron Hydrochloride Injection, 0.25 mg/ml in US.

It has been approved by the US Food and Drug Administration (USFDA) and is a therapeutic equivalent of Aloxi injection. It is used to treat chemotherapy-induced nausea and vomiting sensation.

Further, the injection is available in a single dose vial, packed in a cartoon containing one vial.

Read EquityPandit’s Technical Analysis of Dr Reddy

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



📰
News
📈
Prediction
📊
FII / DII
👔
Advisory
Get 1-2 Index Option Trades Daily